Preclinical development of metalloproteasis inhibitors in cancer therapy. (Q34133632)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Preclinical development of metalloproteasis inhibitors in cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Giavazzi R

1 reference

31 July 2017

Taraboletti G

series ordinal

1 reference

31 July 2017

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

53-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

ECM and cell surface proteolysis: regulating cellular ecology

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Regulation of matrix metalloproteinase expression in tumor invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Structural biochemistry and activation of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Partial purification and characterization of a neutral protease which cleaves type IV collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Cytokine regulation of metalloproteinase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Matrix metalloproteinase inhibition: a review of anti-tumour activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900096-2

7 January 2021

10.1016/S1040-8428(00)00096-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json

release_setzy7h6ong3tbgzovldm5nqoe

3 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/setzy7h6ong3tbgzovldm5nqoe

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11164719%20AND%20SRC:MED&resulttype=core&format=json